| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/11/2002 | EP0880363B1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 09/11/2002 | EP0876367B1 Trans apovincaminic acid ester derivatives as drugs |
| 09/11/2002 | EP0840603B1 Pharmaceutical composition of l-dopa ethyl ester |
| 09/11/2002 | EP0837848B1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 09/11/2002 | EP0823909B1 Novel heterocyclic chemistry |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | EP0797445B1 Use of bioassimilable aqueous boron compounds for the control of subviral pathogenic agents |
| 09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 09/11/2002 | EP0736009B1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs |
| 09/11/2002 | EP0731788B1 Prolyl endopeptidase inhibitors |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368959A Prostaglandin derivatives |
| 09/11/2002 | CN1368892A Sustained release formulation of peptide |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368882A Neuronal death inhibitors |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368878A Drug therapy of restless leg syndrome |
| 09/11/2002 | CN1368876A Compositions and methods of treatment of attention deficit disorder and attention dificit/hyperactivity disorder with methylphenidate |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368361A Nano medicine 'Xiaoer Jingan' and its preparing process |
| 09/11/2002 | CN1368356A Nano medicine 'Tianjingbushen' and its preparing process |
| 09/11/2002 | CN1368329A Nano medicine 'Xiaoer Zhuhuang' and its preparing process |
| 09/11/2002 | CN1368310A Nano medicine 'Tianma Mihuanjun' and its preparing process |
| 09/11/2002 | CN1368256A Nano medicine 'Shenrong Anshen' and its preparing process |
| 09/11/2002 | CN1368239A Nano medicine 'Anshenyangxin' and its preparing process |
| 09/11/2002 | CN1368232A Nano medicine 'Shenqi Wuweizi' and its preparing process |
| 09/11/2002 | CN1368198A Nano medicine 'Compound Yangjiao' and its preparing process |
| 09/11/2002 | CN1368197A Nano medicine 'Anermian' and its preparing process |
| 09/11/2002 | CN1368186A Nano medicine 'Tongguan' and its preparing process |
| 09/11/2002 | CN1368177A Nano medicine 'Shangshiqutong' and its preparing process |
| 09/11/2002 | CN1368153A Nano medicine 'Hupo Huatanzhenjing' and its preparing process |
| 09/11/2002 | CN1368152A Nano medicine 'Guilong' and its preparing process |
| 09/11/2002 | CN1368117A Nano medicine for developing infantile intelligence and its preparing process |
| 09/11/2002 | CN1368116A Nano medicine 'Yangxin Dingji' and its preparing process |
| 09/11/2002 | CN1368111A Nano Medicine 'Yening' and its preparing process |
| 09/11/2002 | CN1368089A Nano medicine 'Miananning' and its preparing process |
| 09/11/2002 | CN1368082A Nano medicine 'Qirong' and its preparing process |
| 09/11/2002 | CN1368079A Nano medicine 'Qingyangshen' and its preparing process |
| 09/11/2002 | CN1368062A Nano medicine 'Zaorenanshen' and its preparing process |
| 09/11/2002 | CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same |
| 09/11/2002 | CN1090629C Novel Heterocyclic compounds |
| 09/11/2002 | CN1090628C New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090503C Medical capsule for treating rheumatism and building up body and its preparing process |
| 09/11/2002 | CN1090499C Sobering and body building tea made of natural plant |
| 09/11/2002 | CN1090498C Quickly-acting antalgic ointment |
| 09/11/2002 | CN1090480C Phenoxy piperazine derivatives for treating disorders of dopamine system |
| 09/11/2002 | CN1090477C Ibuprofen containing solid composition |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448404 Forming the hydrochloride dihydrate; near quantitative elimination of impurities |
| 09/10/2002 | US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction |
| 09/10/2002 | US6448396 Compounds useful as neuro-protective agents |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
| 09/10/2002 | US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
| 09/10/2002 | US6448268 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?) |
| 09/10/2002 | US6448246 Compounds that bind with high selectivity and high affinity to the benzodiazepine site of gaba.sub.a receptors |
| 09/10/2002 | US6448245 Methods of and compounds for inhibiting calpains |
| 09/10/2002 | US6448241 Thiazolobenzoheterocycles, their preparation and medicaments containing them |
| 09/10/2002 | US6448239 Porphyrin ring metallic complexes that are effective peroxynitrite decomposition catalysts for treatment of diseases involving the accumulation of this oxidant, such as altzeimer's disease |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448231 Presynaptic neurotoxin such as botulinum toxin a |
| 09/10/2002 | US6448229 Gamma secretase inhibitors |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447819 Water-soluble complex of an extract of Ginkgo biloba, process for the preparation thereof and composition comprising the same |
| 09/10/2002 | CA2198562C Method of treating conditions with estrogen agonists |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/10/2002 | CA2192208C Substituted pyrazoles |
| 09/10/2002 | CA2119853C Pyridothiadiazines; process for preparing the same and pharmaceutical compositions containing them |
| 09/06/2002 | WO2002068687A2 Function and application of tob gene in central nervous system of mammal |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068425A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 09/06/2002 | WO2002068423A1 Novel substituted imidazotriazinones |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068417A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002068398A1 New crystal forms of lamotrigine and processes for their preparations |
| 09/06/2002 | WO2002068393A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |